Market Research Life Sciences Market Research Medical Devices Market Research Infusion Products Market Research

Latin America Continuous Glucose Monitoring Device Market, by Component type (Transmitters, Receivers, Insulin Pump, and Sensors), by End User (Hospitals & Clinics, Retail Channel, and Online Channel), and by Country (Mexico, Argentina, Uruguay, Brazil, C

Best Price Guarantee Length Publisher Published Date SKU
from $4,500 161 Pages Coherent Market Insights September, 2022 CMI17440790
Best Price Guarantee
Price from $4,500
Length 161 Pages
Publisher Coherent Market Insights
Published Date September, 2022
SKU CMI17440790

Latin America Continuous Glucose Monitoring Device Market, by Component type (Transmitters, Receivers, Insulin Pump, and Sensors), by End User (Hospitals & Clinics, Retail Channel, and Online Channel), and by Country (Mexico, Argentina, Uruguay, Brazil, Colombia, Chile, Peru, and Rest of Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Continuous glucose monitoring devices are considered as significant systems for improving diabetes management by providing better and pain-free blood glucose measurement. Continuous glucose monitoring devices marked a remarkable change in diabetes care, as these devices provide real-time information on blood glucose levels, non-invasively than conventional glucose monitoring devices. Continuous glucose monitoring devices constantly tracks the blood glucose level throughout the day. This device consists of various components such as sensors, transmitters, and receivers for measuring and analyzing the glucose levels.

Market Dynamics

Latin America continuous glucose monitoring device market is expected to witness significant growth over the forecast period, owing to increasing incidence of diabetes in Latin American countries which may result in increasing demand for continuous glucose monitoring device. For instance, in September 2019, according to report published in the International Journal of Diabetes and Clinical Research, Mexico (13.6%) had the highest prevalence of diabetes, whereas significant differences between urban and rural areas were observed (7.8% and 1.4%, respectively) in Latin America. Latin America had the maximum prevalence of type-2 Diabetes problems.

Furthermore, increasing convenience offered by continuous glucose monitoring devices is expected to drive the growth of the Latin America continuous glucose monitoring device market, as display of glucose trend graph and direction arrows allow diabetic patients to anticipate deflection in glucose highs and lows regularly throughout the day, this may increase demand for continuous glucose monitoring devices, which in turn is expected to drive the market growth. Moreover, technological advancements in continuous glucose monitoring components such as use of sensor with long life expectancy in continuous monitoring devices that eliminates the repetitive replacement of sensors is expected to generate remarkable revenue in the market over the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the Latin America continuous glucose monitoring device market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Latin America continuous glucose monitoring device market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Medtronic Plc., Abbott, F. Hoffmann-La Roche AG., Johnson & Johnson, Senseonics, Inc, Dexcom, Inc, Insulet Corporation, Tandem Diabetes Care, Inc, Roche Diagnositics, Lifescan, Bayer Health Care, AgaMatrixc Inc., Arkray Inc., and Nova Biomedical Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Latin America continuous glucose monitoring device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America continuous glucose monitoring device market
Detailed Segmentation:
  • Latin America Continuous Glucose Monitoring Device Market, By Component Type:
  • Transmitters
  • Receivers
  • Insulin Pumps
  • Sensors
  • Latin America Continuous Glucose Monitoring Device Market, By End User:
  • Hospitals & Clinics
  • Homecare
  • Others (Ambulatory Surgical Centers & Academic Institutes)
  • Latin America Continuous Glucose Monitoring Device Market, By Country:
  • Mexico
  • Argentina
  • Uruguay
  • Brazil
  • Colombia
  • Chile
  • Peru
  • Rest of Latin America
  • Company Profiles
  • Medtronic Plc*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Abbott
  • Hoffmann-La Roche AG.
  • Johnson & Johnson
  • Senseonics, Inc
  • Dexcom, Inc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc
  • Roche Diagnositics
  • Lifescan
  • Bayer Health Care
  • AgaMatrixc Inc.
  • Arkray Inc.
  • Nova Biomedical Corporation
“*” marked represents similar segmentation in other categories in the respective section.


Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Market Snapshot, By Component Type  Market Snapshot, By End User  Market Snapshot, By Country o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics  Drivers  Restraints  Market Opportunities o Impact Analysis o Market Trends o PEST Analysis o PORTER’S Five Forces o Mergers and Acquisitions o Product Expiration o Regulatory Scenario 4. Latin America Continuous Glucose Monitoring Device Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Government Initiatives o COVID-19 Impact on the market 5. Latin America Continuous Glucose Monitoring Device Market, By Component Type, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Transmitters  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Receivers  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Insulin Pumps  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Sensors  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 6. Latin America Continuous Glucose Monitoring Device Market, By End User, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, 2022 and 2030 (%)  Y-o-Y Growth Analysis, 2017 – 2030  Segment Trends o Hospitals & Clinics  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Homecare  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Others (Ambulatory Surgical Centers & Academic Institutes)  Overview  Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. Latin America Continuous Glucose Monitoring Device Market, By Country, 2017 – 2030, (US$ Million) o Overview  Market Share Analysis, By Country 2022 and 2030 (%)  Y-o-Y Growth Analysis, By Country, 2017 – 2030  Country Wise Trends o Mexico  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Argentina  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Uruguay  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Brazil  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Colombia  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Chile  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Peru  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) o Rest of Latin America  Introduction  Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2017 - 2030, (US$ Million)  Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million) 8. Competitive Landscape o Heat Map Analysis o Company Profiles  Medtronic Plc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Market Strategies  Abbott o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  F. Hoffmann-La Roche AG. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Johnson & Johnson o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Senseonics, Inc o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Dexcom, Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Insulet Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Tandem Diabetes Care, Inc o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Roche Diagnositics o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Lifescan o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Bayer Health Care o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  AgaMatrixc Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Arkray Inc. o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies  Nova Biomedical Corporation o Company Overview o Product Portfolio o Key Developments o Financial Performance o Strategies 9. Section o References o Research Methodology o About Us and Sales Contact *Browse 33 market data tables and 23 figures on "Latin America Continuous Glucose Monitoring Device Market” - forecast to 2030

$4,500
$7,000
$10,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings